THE VALUES OF MARKERS OF DAMAGE TO THE DISTAL TUBULES IN METABOLIC SYNDROME IN POSTMENOPAUSAL WOMEN
Abstract
Evaluation of the information content of diagnostic laboratory biomarkers of damage to the distal tubules in metabolic syndrome in postmenopausal women.
References
Tomilina N.A., Bikbov B.T. Epidemiology of chronic renal failure and new approaches to the classification and assessment of the severity of chronically progressive kidney diseases //Ter.a rx. -2015.-№6.-S.87-92.
Fomin V.V., Moiseev S.V., Shvetsov M.Yu. Ischemic kidney disease and combined chronic nephropathies: clinical and prognostic features //Ter. Arch.-2007.-№6.-S.44-49.
Koyner JL, Bennett MR, Worcester EM et al. Urinary cystatin C as an early biomarker of acute kidney // Kidney Int. 2008; 74(8): 1059–1069.
Basic SS, Manson JE Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification // Clink. Chem. - 2014. - Vol. 60, no. 1. - R. _ 68-77 .
Bennett MR, Dent CL et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study // Clin . J. Am. soc. Nephrol . 2013; 3(3): 665–673.
Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Sakishima M., Matsuda M., Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome // J. Clink. Invest. - 2014. - Vol. 114. - R. 1752 -1761.
Janssen I., Powell LH, Crawford S., Lesley B., Sutton-Tyrrell K. Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation // Arch. Intern. Med. - 2018. - Vol. 168, no. 14. - R. _ 1568-1575.
